Janus Henderson Group plc 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:09 pm Purchase |
2024-12-31 | 13G | Mereo BioPharma Group plc MREO |
JANUS HENDERSON GROUP PLC JHG |
17,122,563 11.000% |
17,122,563 (New Position) |
Filing |
| 2024-12-06 11:37 am Purchase |
2024-11-29 | 13G | Mereo BioPharma Group plc MREO |
JANUS HENDERSON GROUP PLC JHG |
15,917,259 10.300% |
3,571,393 (+28.93%) |
Filing |
| 2024-11-14 11:44 am Purchase |
2024-09-30 | 13G | Mereo BioPharma Group plc MREO |
JANUS HENDERSON GROUP PLC JHG |
12,345,866 8.000% |
4,400,162 (+55.38%) |
Filing |
| 2024-07-11 11:46 am Purchase |
2024-07-01 | 13G | Mereo BioPharma Group plc MREO |
JANUS HENDERSON GROUP PLC JHG |
7,945,704 5.200% |
7,945,704 (New Position) |
Filing |